Stock Yards Bank & Trust Co. Reduces Stock Holdings in Colgate-Palmolive (NYSE:CL)

Stock Yards Bank & Trust Co. reduced its position in Colgate-Palmolive (NYSE:CLFree Report) by 19.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,690 shares of the company’s stock after selling 4,060 shares during the quarter. Stock Yards Bank & Trust Co.’s holdings in Colgate-Palmolive were worth $1,517,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in CL. Peak Financial Advisors LLC purchased a new stake in Colgate-Palmolive during the fourth quarter valued at about $1,315,000. Gordian Advisors LLC purchased a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $602,000. Carrera Capital Advisors boosted its holdings in Colgate-Palmolive by 23.1% in the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after buying an additional 7,353 shares during the period. Fiduciary Alliance LLC purchased a new position in Colgate-Palmolive in the 4th quarter valued at approximately $4,066,000. Finally, Vontobel Holding Ltd. raised its holdings in Colgate-Palmolive by 224.6% during the 3rd quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock valued at $82,626,000 after acquiring an additional 550,750 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Price Performance

CL stock opened at $87.05 on Tuesday. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41. The firm has a market cap of $71.12 billion, a P/E ratio of 24.73, a P/E/G ratio of 3.61 and a beta of 0.44. The firm’s fifty day moving average is $91.35 and its 200 day moving average is $97.15. Colgate-Palmolive has a 52 week low of $82.68 and a 52 week high of $109.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the company earned $0.87 EPS. Research analysts predict that Colgate-Palmolive will post 3.74 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.30%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Wall Street Analyst Weigh In

Several research firms have issued reports on CL. Stifel Nicolaus dropped their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research report on Monday. JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a report on Monday. Piper Sandler lowered their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. TD Cowen reduced their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $101.16.

Check Out Our Latest Report on CL

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.